United States Healthcare Providers & Services

Natera, Inc. (NTRA)

Natera, Inc. insiders have executed 166 transactions over the past 90 days, exclusively involving sales totaling approximately $226 million. These divestments occurred amid a 38% stock price increase. Key leadership figures, including the CFO and various directors, participated in these planned liquidations ahead of the upcoming November 5th earnings report.
Ticker: NTRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Natera, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
74.74
Quantity 53,073 -8.2%
Value US$4,126,608
2.1
MICHAEL BROPHY Officer Officer
Transaction date
Proposed sale
Price
472.79
Quantity 35,291
Value US$3,551,658
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
87.42
Quantity 13,787 +6.7%
Value US$2,902,903
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
388.20
Quantity 1,000 -0.0%
Value US$100,000
2.1
Chapman Steven Leonard CEO AND PRESIDENT Executive Director
Transaction date
Planned sale
Price
415.64
Quantity 1,000 -3.2%
Value US$100,000
2.1
Chapman Steven Leonard CEO AND PRESIDENT Executive Director
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -1.0%
Value US$100,000
2.1
Chapman Steven Leonard CEO AND PRESIDENT Executive Director
Transaction date
Planned sale
Price
387.90
Quantity 1,000 -0.0%
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -0.7%
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
388.03
Quantity 1,000 -0.0%
Value US$100,000
Fesko John PRESIDENT, CHIEF BUS. OFFICER Officer
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -0.2%
Value US$100,000
Fesko John PRESIDENT, CHIEF BUS. OFFICER Officer
Transaction date
Planned sale
Price
388.20
Quantity 1,000 -0.0%
Value US$100,000
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Officer
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -0.2%
Value US$100,000
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Officer
Transaction date
Planned sale
Price
388.20
Quantity 1,000 -0.0%
Value US$100,000
2.4
Rabinowitz Matthew EXECUTIVE CHAIRMAN Executive Director
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -0.0%
Value US$100,000
2.4
Rabinowitz Matthew EXECUTIVE CHAIRMAN Executive Director
Transaction date
Planned sale
Price
388.20
Quantity 1,000 -0.0%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
416.45
Quantity 1,000 -0.2%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
415.52
Quantity 1,000 -0.7%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
414.16
Quantity 1,000 -0.1%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
412.88
Quantity 1,000 -0.1%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
411.73
Quantity 1,000 -0.1%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
410.72
Quantity 1,000 -0.1%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
409.46
Quantity 1,000 -0.5%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
408.08
Quantity 1,000 -0.4%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
406.94
Quantity 1,000 -0.4%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
405.26
Quantity 1,000 -0.2%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
400.29
Quantity 1,000 -0.4%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
388.20
Quantity 1,000 -0.0%
Value US$100,000
2.1
STEVEN L CHAPMAN Officer; Director Executive Director
Transaction date
Proposed sale
Price
415.64
Quantity 1,000
Value US$100,000
2.1
JONATHAN SHEENA DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
DANIEL RABINOWITZ OFFICER Officer
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
2.4
MATTHEW RABINOWITZ DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
2.4
SOLOMON MOSHKEVICH OFFICER Officer
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
2.1
MICHAEL BROPHY OFFICER Officer
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
2.1
STEVEN CHAPMAN OFFICER; DIRECTOR Executive Director
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
JOHN FESKO OFFICER Officer
Transaction date
Proposed sale
Price
414.30
Quantity 1,000
Value US$100,000
2.4
SOLOMON MOSHKEVICH Officer Officer
Transaction date
Proposed sale
Price
411.13
Quantity 1,000
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
425.55
Quantity 1,000 -3.9%
Value US$100,000
2.1
MICHAEL BROPHY Officer Officer
Transaction date
Proposed sale
Price
436.00
Quantity 1,000
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
426.87
Quantity 1,000 -1.8%
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
425.32
Quantity 1,000 -0.6%
Value US$100,000
Fesko John PRESIDENT, CHIEF BUS. OFFICER Officer
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -0.5%
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -2.4%
Value US$100,000
2.1
Chapman Steven Leonard CEO AND PRESIDENT Executive Director
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -3.6%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -1.1%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -0.1%
Value US$100,000
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Officer
Transaction date
Planned sale
Price
426.34
Quantity 1,000 -0.6%
Value US$100,000
2.1
MICHAEL BROPHY Officer Officer
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
2.1
JONATHAN SHEENA DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
DANIEL RABINOWITZ OFFICER Officer
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
JOHN FESKO OFFICER Officer
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
2.1
STEVEN CHAPMAN OFFICER; DIRECTOR Executive Director
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
2.4
SOLOMON MOSHKEVICH OFFICER Officer
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
2.1
MICHAEL BROPHY OFFICER Officer
Transaction date
Proposed sale
Price
410.82
Quantity 1,000
Value US$100,000
Fesko John PRESIDENT, CHIEF BUS. OFFICER Officer
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -0.4%
Value US$100,000
2.4
Rabinowitz Matthew EXECUTIVE CHAIRMAN Executive Director
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -0.1%
Value US$100,000
2.1
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -1.5%
Value US$100,000
2.1
Chapman Steven Leonard CEO AND PRESIDENT Executive Director
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -2.3%
Value US$100,000
2.4
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Officer
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -0.9%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -0.1%
Value US$100,000
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Officer
Transaction date
Planned sale
Price
406.00
Quantity 1,000 -0.5%
Value US$100,000
2.4
MATTHEW RABINOWITZ DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
DANIEL RABINOWITZ OFFICER Officer
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
2.1
JONATHAN SHEENA DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
2.4
SOLOMON MOSHKEVICH OFFICER Officer
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
JOHN FESKO OFFICER Officer
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
2.1
STEVEN CHAPMAN OFFICER; DIRECTOR Executive Director
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
2.1
MICHAEL BROPHY OFFICER Officer
Transaction date
Proposed sale
Price
404.90
Quantity 1,000
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
416.67
Quantity 1,000 -0.1%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
415.67
Quantity 1,000 -0.1%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
413.05
Quantity 1,000 -0.1%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
412.20
Quantity 1,000 -0.1%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
411.32
Quantity 1,000 -0.3%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
409.89
Quantity 1,000 -0.3%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
408.26
Quantity 1,000 -0.4%
Value US$100,000
2.1
Sheena Jonathan Non-Executive Director
Transaction date
Planned sale
Price
406.50
Quantity 1,000 -0.1%
Value US$100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-04 2026-11-03 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
53,073 -8.2%
74.74
US$4,126,608 		53,073 -8.2% 74.74 US$4,126,608
2026-11-03 2026-11-03 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
35,291
472.79
US$3,551,658 		35,291 472.79 US$3,551,658
2026-11-04 2026-11-02 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
13,787 +6.7%
87.42
US$2,902,903 		13,787 +6.7% 87.42 US$2,902,903
2026-11-04 2026-11-02 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.0%
388.20
US$100,000 		1,000 -0.0% 388.20 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -3.2%
415.64
US$100,000 		1,000 -3.2% 415.64 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -1.0%
400.29
US$100,000 		1,000 -1.0% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.0%
387.90
US$100,000 		1,000 -0.0% 387.90 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.7%
400.29
US$100,000 		1,000 -0.7% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.0%
388.03
US$100,000 		1,000 -0.0% 388.03 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.2%
400.29
US$100,000 		1,000 -0.2% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.0%
388.20
US$100,000 		1,000 -0.0% 388.20 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.2%
400.29
US$100,000 		1,000 -0.2% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.0%
388.20
US$100,000 		1,000 -0.0% 388.20 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Rabinowitz Matthew

EXECUTIVE CHAIRMAN

Executive Director
1,000 -0.0%
400.29
US$100,000 		1,000 -0.0% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Rabinowitz Matthew

EXECUTIVE CHAIRMAN

Executive Director
1,000 -0.0%
388.20
US$100,000 		1,000 -0.0% 388.20 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.2%
416.45
US$100,000 		1,000 -0.2% 416.45 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.7%
415.52
US$100,000 		1,000 -0.7% 415.52 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
414.16
US$100,000 		1,000 -0.1% 414.16 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
412.88
US$100,000 		1,000 -0.1% 412.88 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
411.73
US$100,000 		1,000 -0.1% 411.73 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
410.72
US$100,000 		1,000 -0.1% 410.72 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.5%
409.46
US$100,000 		1,000 -0.5% 409.46 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.4%
408.08
US$100,000 		1,000 -0.4% 408.08 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.4%
406.94
US$100,000 		1,000 -0.4% 406.94 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.2%
405.26
US$100,000 		1,000 -0.2% 405.26 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.4%
400.29
US$100,000 		1,000 -0.4% 400.29 US$100,000
2026-11-04 2026-11-02 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.0%
388.20
US$100,000 		1,000 -0.0% 388.20 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.1
STEVEN L CHAPMAN

Officer; Director

Executive Director
1,000
415.64
US$100,000 		1,000 415.64 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.1
JONATHAN SHEENA

DIRECTOR

Non-Executive Director
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.4
MATTHEW RABINOWITZ

DIRECTOR

Non-Executive Director
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
JOHN FESKO

OFFICER

Officer
1,000
414.30
US$100,000 		1,000 414.30 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

Officer

Officer
1,000
411.13
US$100,000 		1,000 411.13 US$100,000
2026-10-30 2026-10-30 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -3.9%
425.55
US$100,000 		1,000 -3.9% 425.55 US$100,000
2026-10-30 2026-10-30 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
1,000
436.00
US$100,000 		1,000 436.00 US$100,000
2026-10-30 2026-10-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -1.8%
426.87
US$100,000 		1,000 -1.8% 426.87 US$100,000
2026-10-30 2026-10-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.6%
425.32
US$100,000 		1,000 -0.6% 425.32 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.5%
426.34
US$100,000 		1,000 -0.5% 426.34 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -2.4%
426.34
US$100,000 		1,000 -2.4% 426.34 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -3.6%
426.34
US$100,000 		1,000 -3.6% 426.34 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -1.1%
426.34
US$100,000 		1,000 -1.1% 426.34 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
426.34
US$100,000 		1,000 -0.1% 426.34 US$100,000
2026-10-29 2026-10-28 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.6%
426.34
US$100,000 		1,000 -0.6% 426.34 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
2.1
JONATHAN SHEENA

DIRECTOR

Non-Executive Director
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
JOHN FESKO

OFFICER

Officer
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-28 2026-10-28 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
410.82
US$100,000 		1,000 410.82 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.4%
406.00
US$100,000 		1,000 -0.4% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
2.4
Rabinowitz Matthew

EXECUTIVE CHAIRMAN

Executive Director
1,000 -0.1%
406.00
US$100,000 		1,000 -0.1% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -1.5%
406.00
US$100,000 		1,000 -1.5% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -2.3%
406.00
US$100,000 		1,000 -2.3% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.9%
406.00
US$100,000 		1,000 -0.9% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
406.00
US$100,000 		1,000 -0.1% 406.00 US$100,000
2026-10-29 2026-10-27 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.5%
406.00
US$100,000 		1,000 -0.5% 406.00 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
2.4
MATTHEW RABINOWITZ

DIRECTOR

Non-Executive Director
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
2.1
JONATHAN SHEENA

DIRECTOR

Non-Executive Director
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
JOHN FESKO

OFFICER

Officer
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-27 2026-10-27 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
404.90
US$100,000 		1,000 404.90 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
416.67
US$100,000 		1,000 -0.1% 416.67 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
415.67
US$100,000 		1,000 -0.1% 415.67 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
413.05
US$100,000 		1,000 -0.1% 413.05 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
412.20
US$100,000 		1,000 -0.1% 412.20 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.3%
411.32
US$100,000 		1,000 -0.3% 411.32 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.3%
409.89
US$100,000 		1,000 -0.3% 409.89 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.4%
408.26
US$100,000 		1,000 -0.4% 408.26 US$100,000
2026-10-23 2026-10-21 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
406.50
US$100,000 		1,000 -0.1% 406.50 US$100,000

See older Natera, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Natera, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Natera, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America